Metastatic Melanoma Diagnostic Market, Global Outlook and Forecast 2023-2028

Report ID: 1212917 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Metastatic Melanoma Diagnostic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Metastatic Melanoma Diagnostic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Metastatic Melanoma Diagnostic Overall Market Size
    2.1 Global Metastatic Melanoma Diagnostic Market Size: 2021 VS 2028
    2.2 Global Metastatic Melanoma Diagnostic Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Metastatic Melanoma Diagnostic Players in Global Market
    3.2 Top Global Metastatic Melanoma Diagnostic Companies Ranked by Revenue
    3.3 Global Metastatic Melanoma Diagnostic Revenue by Companies
    3.4 Top 3 and Top 5 Metastatic Melanoma Diagnostic Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Metastatic Melanoma Diagnostic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Players in Global Market
        3.6.1 List of Global Tier 1 Metastatic Melanoma Diagnostic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Metastatic Melanoma Diagnostic Market Size Markets, 2021 & 2028
        4.1.2 BRAF Mutation
        4.1.3 Circulating Tumor Cells (CTCs)
        4.1.4 Immunohistochemistry
        4.1.5 Others
    4.2 By Type - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
        4.2.1 By Type - Global Metastatic Melanoma Diagnostic Revenue, 2017-2022
        4.2.2 By Type - Global Metastatic Melanoma Diagnostic Revenue, 2023-2028
        4.2.3 By Type - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Metastatic Melanoma Diagnostic Market Size, 2021 & 2028
        5.1.2 Pathology Laboratories
        5.1.3 Hospitals
        5.1.4 Cancer Research Centres
        5.1.5 Others
    5.2 By Application - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
        5.2.1 By Application - Global Metastatic Melanoma Diagnostic Revenue, 2017-2022
        5.2.2 By Application - Global Metastatic Melanoma Diagnostic Revenue, 2023-2028
        5.2.3 By Application - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Metastatic Melanoma Diagnostic Market Size, 2021 & 2028
    6.2 By Region - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
        6.2.1 By Region - Global Metastatic Melanoma Diagnostic Revenue, 2017-2022
        6.2.2 By Region - Global Metastatic Melanoma Diagnostic Revenue, 2023-2028
        6.2.3 By Region - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Metastatic Melanoma Diagnostic Revenue, 2017-2028
        6.3.2 US Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.3.3 Canada Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.3.4 Mexico Metastatic Melanoma Diagnostic Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Metastatic Melanoma Diagnostic Revenue, 2017-2028
        6.4.2 Germany Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.4.3 France Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.4.4 U.K. Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.4.5 Italy Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.4.6 Russia Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.4.7 Nordic Countries Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.4.8 Benelux Metastatic Melanoma Diagnostic Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Metastatic Melanoma Diagnostic Revenue, 2017-2028
        6.5.2 China Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.5.3 Japan Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.5.4 South Korea Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.5.5 Southeast Asia Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.5.6 India Metastatic Melanoma Diagnostic Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Metastatic Melanoma Diagnostic Revenue, 2017-2028
        6.6.2 Brazil Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.6.3 Argentina Metastatic Melanoma Diagnostic Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue, 2017-2028
        6.7.2 Turkey Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.7.3 Israel Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.7.4 Saudi Arabia Metastatic Melanoma Diagnostic Market Size, 2017-2028
        6.7.5 UAE Metastatic Melanoma Diagnostic Market Size, 2017-2028
7 Players Profiles
    7.1 Myriad Genetics
        7.1.1 Myriad Genetics Corporate Summary
        7.1.2 Myriad Genetics Business Overview
        7.1.3 Myriad Genetics Metastatic Melanoma Diagnostic Major Product Offerings
        7.1.4 Myriad Genetics Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.1.5 Myriad Genetics Key News
    7.2 Abbott Laboratories
        7.2.1 Abbott Laboratories Corporate Summary
        7.2.2 Abbott Laboratories Business Overview
        7.2.3 Abbott Laboratories Metastatic Melanoma Diagnostic Major Product Offerings
        7.2.4 Abbott Laboratories Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.2.5 Abbott Laboratories Key News
    7.3 Foundation Medicine
        7.3.1 Foundation Medicine Corporate Summary
        7.3.2 Foundation Medicine Business Overview
        7.3.3 Foundation Medicine Metastatic Melanoma Diagnostic Major Product Offerings
        7.3.4 Foundation Medicine Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.3.5 Foundation Medicine Key News
    7.4 Pathway Genomics Corporation
        7.4.1 Pathway Genomics Corporation Corporate Summary
        7.4.2 Pathway Genomics Corporation Business Overview
        7.4.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Major Product Offerings
        7.4.4 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.4.5 Pathway Genomics Corporation Key News
    7.5 Cancer Genetics
        7.5.1 Cancer Genetics Corporate Summary
        7.5.2 Cancer Genetics Business Overview
        7.5.3 Cancer Genetics Metastatic Melanoma Diagnostic Major Product Offerings
        7.5.4 Cancer Genetics Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.5.5 Cancer Genetics Key News
    7.6 Castle Biosciences
        7.6.1 Castle Biosciences Corporate Summary
        7.6.2 Castle Biosciences Business Overview
        7.6.3 Castle Biosciences Metastatic Melanoma Diagnostic Major Product Offerings
        7.6.4 Castle Biosciences Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.6.5 Castle Biosciences Key News
    7.7 NeoGenomics
        7.7.1 NeoGenomics Corporate Summary
        7.7.2 NeoGenomics Business Overview
        7.7.3 NeoGenomics Metastatic Melanoma Diagnostic Major Product Offerings
        7.7.4 NeoGenomics Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.7.5 NeoGenomics Key News
    7.8 Dermtech
        7.8.1 Dermtech Corporate Summary
        7.8.2 Dermtech Business Overview
        7.8.3 Dermtech Metastatic Melanoma Diagnostic Major Product Offerings
        7.8.4 Dermtech Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.8.5 Dermtech Key News
    7.9 Sysmex Inostics
        7.9.1 Sysmex Inostics Corporate Summary
        7.9.2 Sysmex Inostics Business Overview
        7.9.3 Sysmex Inostics Metastatic Melanoma Diagnostic Major Product Offerings
        7.9.4 Sysmex Inostics Metastatic Melanoma Diagnostic Revenue in Global Market (2017-2022)
        7.9.5 Sysmex Inostics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Metastatic Melanoma Diagnostic Market Opportunities & Trends in Global Market
    Table 2. Metastatic Melanoma Diagnostic Market Drivers in Global Market
    Table 3. Metastatic Melanoma Diagnostic Market Restraints in Global Market
    Table 4. Key Players of Metastatic Melanoma Diagnostic in Global Market
    Table 5. Top Metastatic Melanoma Diagnostic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Metastatic Melanoma Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Metastatic Melanoma Diagnostic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Metastatic Melanoma Diagnostic Product Type
    Table 9. List of Global Tier 1 Metastatic Melanoma Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Metastatic Melanoma Diagnostic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Metastatic Melanoma Diagnostic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 30. Myriad Genetics Corporate Summary
    Table 31. Myriad Genetics Metastatic Melanoma Diagnostic Product Offerings
    Table 32. Myriad Genetics Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 33. Abbott Laboratories Corporate Summary
    Table 34. Abbott Laboratories Metastatic Melanoma Diagnostic Product Offerings
    Table 35. Abbott Laboratories Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 36. Foundation Medicine Corporate Summary
    Table 37. Foundation Medicine Metastatic Melanoma Diagnostic Product Offerings
    Table 38. Foundation Medicine Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 39. Pathway Genomics Corporation Corporate Summary
    Table 40. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Product Offerings
    Table 41. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 42. Cancer Genetics Corporate Summary
    Table 43. Cancer Genetics Metastatic Melanoma Diagnostic Product Offerings
    Table 44. Cancer Genetics Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 45. Castle Biosciences Corporate Summary
    Table 46. Castle Biosciences Metastatic Melanoma Diagnostic Product Offerings
    Table 47. Castle Biosciences Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 48. NeoGenomics Corporate Summary
    Table 49. NeoGenomics Metastatic Melanoma Diagnostic Product Offerings
    Table 50. NeoGenomics Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 51. Dermtech Corporate Summary
    Table 52. Dermtech Metastatic Melanoma Diagnostic Product Offerings
    Table 53. Dermtech Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 54. Sysmex Inostics Corporate Summary
    Table 55. Sysmex Inostics Metastatic Melanoma Diagnostic Product Offerings
    Table 56. Sysmex Inostics Metastatic Melanoma Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Metastatic Melanoma Diagnostic Segment by Type in 2021
    Figure 2. Metastatic Melanoma Diagnostic Segment by Application in 2021
    Figure 3. Global Metastatic Melanoma Diagnostic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Metastatic Melanoma Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Metastatic Melanoma Diagnostic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Metastatic Melanoma Diagnostic Revenue in 2021
    Figure 8. By Type - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 12. US Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 16. Germany Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 24. China Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 30. Brazil Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue Market Share, 2017-2028
    Figure 33. Turkey Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 37. Myriad Genetics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Abbott Laboratories Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Foundation Medicine Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Cancer Genetics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Castle Biosciences Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. NeoGenomics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Dermtech Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Sysmex Inostics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Metastatic Melanoma Diagnostic Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metastatic Melanoma Diagnostic Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metastatic Melanoma Diagnostic Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports